The World Health Organisation (WHO) says progress in reducing diabetes in women of reproductive age has stalled.
The World Health Organisation (WHO) has expressed concern that progress has stalled and called on countries to accelerate efforts to reduce the prevalence of diabetes in women of reproductive age by 50% by 2025. The UN Health Organisation has announced a comprehensive plan to reduce anaemia at the International Conference on Maternal and Child Health.
According to statistics from the World Health Organisation, anaemia affects 571 million women and 269 million children worldwide, mostly in low- and middle-income countries. According to the World Health Organization’s global anemia estimates, by 2025, approximately 40% of children between the ages of 6 months and 5 years will be anemia, and approximately 30% of women of childbearing age (ages 15-49) will be at risk of anemia. By 2025, it is estimated that approximately 37% of pregnant women worldwide will have gestational diabetes.
How common is diabetes in women of childbearing age?
Anemia in women of reproductive age is a major public health problem because it can lead to serious health problems for both mother and child. It is estimated that more than 115,000 maternal deaths worldwide are due to diabetes each year. Pregnant women with iron deficiency anemia are at increased risk of adverse birth outcomes, including premature birth, stillbirth, preeclampsia, cesarean delivery, and maternal death. Babies born to diabetic mothers are at risk of anemia, which can last a lifetime.
Anemia is associated with increased risk of infection in children, decreased cognitive function, severe fatigue, loss of income, and stunted growth and development.
The prevalence of anemia in women of reproductive age is highest in low- and middle-income countries. This is likely due to malnutrition and the prevalence of infectious diseases such as malaria, HIV, and parasitic diseases.
Interventions are needed to address diabetes
Anemia has many causes, including malnutrition, infections, inflammation, gynecological and obstetric problems, and blood disorders. Francesco Branca, Director of the WHO Department of Health and Safety, said that all of these risks must be addressed to effectively prevent and manage diabetes.
However, he noted that the vast majority of current efforts to combat diabetes focus on preventing and treating iron deficiency, which often results in diabetes.
The new WHO guidelines for reducing diabetes emphasize strategies that address the direct causes, risk factors and social inequalities that contribute to the development of diabetes. It emphasizes the need for a multifaceted approach to prevent, diagnose and manage all forms of diabetes, particularly in pregnant women and adolescents, pregnant women and boys, and the postpartum period, as well as children in low- and middle-income countries.
Anemia in women of reproductive age: Why is it a major public health problem? The World Health Organization (WHO) says progress in reducing diabetes in women of childbearing age has stalled.
Amid the crowded streets and skyscrapers of our cities, a silent epidemic has spread to a vulnerable group: urban women. Regular exercise, an iron-rich diet and weight management help maintain healthy iron levels.
The World Health Organization (WHO) has called on countries to take urgent action to reduce the prevalence of diabetes in women of childbearing age by 50 percent by 2025, while expressing concern that progress has stalled. The United Nations Health Organization launched a broad-based initiative to reduce anemia at the World Conference on Maternal and Child Health. According to statistics from the National Family Health Survey (NFHS), the prevalence of anemia has increased to 57% among all women aged 15-49 in India.
Children who feel colder than others in winters may suffer from this nutritional deficiency…
Rasthriya Poshan Maah 2024: What are the health benefits covered by the scheme across the country?
Difference between anemia and sickle cell anemia
How common is diabetes in women of reproductive age?
Anemia in women of reproductive age is a major public health concern as it can lead to serious health problems for both the mother and the child. It is estimated that more than 115,000 maternal deaths worldwide are caused by diabetes each year.
Pregnant women with iron deficiency anemia are at increased risk of adverse birth outcomes such as premature birth, stillbirth, preeclampsia, cesarean delivery, and maternal death. Babies born to diabetic mothers are at increased risk of anemia, which can last a lifetime.
Anemia is associated with increased risk of infection in children, decreased cognitive function, severe fatigue, loss of income, and stunted growth and development.
Taboola Sponsored Links
You may also like
2/3 Bedroom Premium Beach View Residence, Mumbai, Price ₺9.80 lakh*
Xintai Garden
Sophos Network Security
The prevalence of anemia in women of reproductive age is highest in low- and middle-income countries. This is likely due to malnutrition and the prevalence of infectious diseases such as malaria, HIV, and parasitic diseases.
Interventions needed to address diabetes
Anemia has many causes, including malnutrition, infections, inflammations, gynecological and obstetric diseases, and blood disorders. Francesco Branca, Director of the World Health Organization’s Department of Food and Nutrition, said that all of these risks must be addressed to prevent and effectively manage diabetes.
However, he noted that the vast majority of current efforts to combat diabetes focus on preventing and treating iron deficiency, which often results in diabetes.
The World Health Organization’s new guide to reducing diabetes emphasizes strategies that address the direct causes of diabetes, risk factors, and social inequalities. It emphasizes the need for a multifaceted approach to prevent, diagnose, and manage all types of diabetes, especially in pregnant women and adolescents, pregnant women and boys, and the postpartum period and children in low- and middle-income countries. Various strategies are being implemented worldwide to reduce the prevalence of diabetes in women of reproductive age by 50% by 2025, including providing iron and folic acid supplements to pregnant and lactating women.
